Cancer
Ceritinib in ALK-rearranged non–small-cell lung cancer![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Shaw A, et al. N Engl J Med 2014; 370:1189-1197March 27, 2014
Shaw A, et al. N Engl J Med 2014; 370:1189-1197March 27, 2014
Clinical applications of melanoma genetics
Gabree M, et al. Curr Treat Options Oncol 2014 Mar
Gabree M, et al. Curr Treat Options Oncol 2014 Mar
Clinical validation of the detection of KRAS and BRAFmutations from circulating tumor DNA![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Alain R Thierry et al. Nature Medicine, March 23, 2014
Alain R Thierry et al. Nature Medicine, March 23, 2014
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
André F, et al. The Lancet Oncology, Volume 15, Issue 3, Pages 267 - 274, March 2014
André F, et al. The Lancet Oncology, Volume 15, Issue 3, Pages 267 - 274, March 2014
Low response in metastatic breast cancer study despite precision approach shows real world challenge,
Genome Web, Mar 25 [by free subscription only]
Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through
Cragun D, et al. Genet Med 2014 Mar
Cragun D, et al. Genet Med 2014 Mar
Evaluation and correlation of risk recurrence in early breast cancer assessed by Oncotype DX, clinicopathological markers and tumor cell dissemination in the blood and bone marrow
Aktas B, et al. Mol Clin Oncol 2013 Nov;1(6):1049-54
Aktas B, et al. Mol Clin Oncol 2013 Nov;1(6):1049-54
Physicians' attitudes about multiplex tumor genomic testing![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vOkHr9hY24SDMzkVM2iUOXfIhqzUiqUlvYrAtOFFk0w5uVVJbXYGfx7VBrBflBpn92jbUG7WOCJSMPV2leo-6k7u6JZ0omR8iphwnji-lXPZwAaFf8SAAS=s0-d)
Gray SW, et al. J Clin Oncol 2014 Mar 24
Gray SW, et al. J Clin Oncol 2014 Mar 24
Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer
Kim do Y, et al. J Surg Oncol 2014 Mar;109(3):250-4
Kim do Y, et al. J Surg Oncol 2014 Mar;109(3):250-4
No hay comentarios:
Publicar un comentario